CALTON & ASSOCIATES, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
CALTON & ASSOCIATES, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$113,848
-3.0%
22,907
-3.6%
0.05%
-1.9%
Q1 2023$117,382
+14.4%
23,761
+45.6%
0.05%
+35.0%
Q4 2022$102,616
-16.6%
16,314
+42.3%
0.04%
-42.9%
Q3 2022$123,000
-37.6%
11,468
-33.9%
0.07%
-35.8%
Q2 2022$197,000
+18.7%
17,352
-5.3%
0.11%
+122.4%
Q1 2022$166,000
-32.2%
18,329
+92.0%
0.05%
-9.3%
Q3 2021$245,000
+14.5%
9,546
+57.3%
0.05%
+28.6%
Q1 2021$214,0006,0670.04%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders